Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Latest predictions
-
23.11.20
buy
-
31.05.20
buy
€54.12
03.07.19
buy
Your prediction

Simulations Plus Stock

Simulations Plus took a tumble today and lost -€2.500 (-4.100%).
Our community is currently high on Simulations Plus with 3 Buy predictions and 0 Sell predictions.
On the other hand, the target price of €54.00 is below the current price of €58.50 for Simulations Plus, so the potential is actually -7.692%.

Pros and Cons of Simulations Plus in the next few years

Pros
?
Growth compared to competition
?
Conscious of the environment
?
Brand
Cons
?
Shareholder structure
?
Worthwhile Investment for the next years
?
Market Position
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Simulations Plus vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
Simulations Plus -4.100% -6.400% -9.302% 97.635% 0.862% 355.963% 571.642%
Harvard Bioscience -1.650% -3.243% -2.186% 26.056% 6.548% -7.254% 42.914%
Allscripts Healthcare -0.780% -6.618% -5.224% 85.401% 11.404% 12.092% -
Genmark Diagnostics 3.070% -4.678% 41.739% 415.823% 39.316% 350.276% 131.337%

Other discussions about Simulations Plus Stock

New thread Forum

News

Simulations Plus and the University of Pittsburgh Drug Discovery Institute Receive SBIR Grant Funding for Large Molecule Safety Collaboration: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus and the University of Pittsburgh Drug Discovery Institute Receive SBIR Grant Funding for Large Molecule Safety Collaboration


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its DILIsym Services (DSS)

Simulations Plus to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference


Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that Shawn

Simulations Plus Releases GastroPlus® Version 9.8.1: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Releases GastroPlus® Version 9.8.1


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it